Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

OBJECTIVE: To assess and compare the incidence of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKi), tumour necrosis factor inhibitors (TNFi) or other biological disease modifying antirheumatic drugs (bDMARDs). For contextualisation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Molander, Viktor, Bower, Hannah, Frisell, Thomas, Delcoigne, Benedicte, Di Giuseppe, Daniela, Askling, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887398/
https://www.ncbi.nlm.nih.gov/pubmed/36150749
http://dx.doi.org/10.1136/ard-2022-223050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887398/
https://www.ncbi.nlm.nih.gov/pubmed/36150749
http://dx.doi.org/10.1136/ard-2022-223050

Ejemplares similares